Welcome to Shulov Institute for Science

Natural substances, and in particular venoms and toxins and their derivatives, are well known to be a rich reservoir of health supporting molecules. SIS offers an innovative compound based on the results of a research program devoted to the separation of the therapeutic and toxic components from snake venom. The peptide chain that has been isolated from this program demonstrates analgesic properties with a delayed onset and a prolonged duration of action. This makes it particularly attractive to the rapidly growing multi billion dollar chronic pain market.

The analgesic Zep-3 is inexpensive to synthesize, easy to standardize and appears to be non-toxic and non-addictive. SIS is currently planning pre-clinical testing and Phase 1 trials and welcomes inquiries from interested partners or investors.

Please look around our website, watch a short video clip on SIS, or contact us for more information.

S.I.S. (Shulov Institute for Science) Ltd.